BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14712218)

  • 1. Insulin-like growth factor-I signaling in human neuroblastoma cells.
    Kim B; van Golen CM; Feldman EL
    Oncogene; 2004 Jan; 23(1):130-41. PubMed ID: 14712218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B; Leventhal PS; White MF; Feldman EL
    Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
    Kim B; van Golen CM; Feldman EL
    Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin-like growth factor-I signaling by ethanol in neuronal cells.
    Hallak H; Seiler AE; Green JS; Henderson A; Ross BN; Rubin R
    Alcohol Clin Exp Res; 2001 Jul; 25(7):1058-64. PubMed ID: 11505033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
    Hermanto U; Zong CS; Li W; Wang LH
    Mol Cell Biol; 2002 Apr; 22(7):2345-65. PubMed ID: 11884618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins.
    Ivankovic-Dikic I; Grönroos E; Blaukat A; Barth BU; Dikic I
    Nat Cell Biol; 2000 Sep; 2(9):574-81. PubMed ID: 10980697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance.
    Leventhal PS; Shelden EA; Kim B; Feldman EL
    J Biol Chem; 1997 Feb; 272(8):5214-8. PubMed ID: 9030591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility.
    Mañes S; Mira E; Gómez-Mouton C; Zhao ZJ; Lacalle RA; Martínez-A C
    Mol Cell Biol; 1999 Apr; 19(4):3125-35. PubMed ID: 10082579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of insulin-like growth factor-1 receptor and IRS-2 signaling by ethanol in SH-SY5Y neuroblastoma cells.
    Seiler AE; Ross BN; Rubin R
    J Neurochem; 2001 Jan; 76(2):573-81. PubMed ID: 11208920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.
    Morrione A; Navarro M; Romano G; Dews M; Reiss K; Valentinis B; Belletti B; Baserga R
    Oncogene; 2001 Aug; 20(35):4842-52. PubMed ID: 11521195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphavbeta3 integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration.
    Kabir-Salmani M; Shiokawa S; Akimoto Y; Sakai K; Nagamatsu S; Sakai K; Nakamura Y; Lotfi A; Kawakami H; Iwashita M
    Endocrinology; 2003 Apr; 144(4):1620-30. PubMed ID: 12639947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and insulin-like growth factor-1 stimulate dephosphorylation of paxillin in parallel with focal adhesion kinase.
    Konstantopoulos N; Clark S
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):387-90. PubMed ID: 8670044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth.
    Blakesley VA; Koval AP; Stannard BS; Scrimgeour A; LeRoith D
    J Biol Chem; 1998 Jul; 273(29):18411-22. PubMed ID: 9660809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells.
    Misawa A; Hosoi H; Arimoto A; Shikata T; Akioka S; Matsumura T; Houghton PJ; Sawada T
    Cancer Res; 2000 Jan; 60(1):64-9. PubMed ID: 10646854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the phosphatidylinositol-3' kinase pathway and DNA synthesis by a mutant insulin-like growth factor I receptor lacking the NPXY motif.
    Kataoka K; Yu D; Miura M
    J Endocrinol; 2004 Apr; 181(1):139-46. PubMed ID: 15072574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor-Mediated Signaling in Neuroblastoma.
    Soori M; Lu G; Mason RW
    J Pharmacol Exp Ther; 2016 Feb; 356(2):375-86. PubMed ID: 26660229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration.
    Zhang X; Lin M; van Golen KL; Yoshioka K; Itoh K; Yee D
    Breast Cancer Res Treat; 2005 Sep; 93(2):159-68. PubMed ID: 16187236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.